Warther Private Wealth, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Warther Private Wealth, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$902.69 - $993.35 $136,306 - $149,995	-151 Reduced 5.92%	2,398 $2.31 Million
Q4 2023 Feb 07, 2024	SELL	$775.18 - $881.7 $648,825 - $737,982	-837 Reduced 24.72%	2,549 $2.24 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $36,007 - $43,907	52 Added 1.56%	3,386 $2.79 Million
Q2 2023 Jul 31, 2023	SELL	$700.03 - $830.35 $182,007 - $215,891	-260 Reduced 7.23%	3,334 $2.4 Million
Q1 2023 May 30, 2023	BUY	$680.49 - $826.97 $37,426 - $45,483	55 Added 1.55%	3,594 $2.95 Million
Q4 2022 Feb 03, 2023	SELL	$705.89 - $766.39 $100,236 - $108,827	-142 Reduced 3.86%	3,539 $2.55 Million
Q3 2022 Nov 16, 2022	BUY	$573.97 - $724.32 $2.11 Million - $2.67 Million	3,681 New	3,681 $2.54 Million
Q2 2022 Dec 30, 2022	SELL	$548.35 - $738.84 $1.02 Million - $1.38 Million	-1,865 Reduced 50.67%	1,816 $1.08 Million
Q1 2022 Dec 30, 2022	SELL	$595.12 - $698.43 $1.92 Million - $2.26 Million	-3,232 Reduced 87.8%	449 $312,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Warther Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Warther Private Wealth, LLC with notifications on news.